Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

S Bringhen, M D'Agostino, L De Paoli, V Montefusco, A M Liberati, P Galieni, S Grammatico, V E Muccio, F Esma, C De Angelis, P Musto, S Ballanti, M Offidani, M T Petrucci, G Gaidano, P Corradini, A Palumbo, P Sonneveld, M Boccadoro

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences